Surface expression of the activating receptor NKG2D and the activating coreceptor DNAM-1 were decreased in COVID-19 patients compared with healthy controls while having greatly increased intracellular expression of the cytotoxic molecules Granzyme B and Perforin and the proliferation marker Ki-67. This evidence concerns the gene CD226 and COVID-19.